About Gloucester Pharmaceuticals
Gloucester Pharmaceuticals is a company based in Cambridge (United States) founded in 2002 was acquired by Celgene in December 2009.. Gloucester Pharmaceuticals has raised $33 million across 5 funding rounds from investors including Celgene, Apple Tree Partners and ProQuest Investments. Gloucester Pharmaceuticals operates in a competitive market with competitors including Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others.
- Headquarter Cambridge, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Gloucester Pharmaceuticals Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Gloucester Pharmaceuticals
Gloucester Pharmaceuticals has successfully raised a total of $33M across 5 strategic funding rounds. The most recent funding activity was a Series D round of $29 million completed in August 2009. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series D — $29.0M
-
First Round
First Round
(30 Mar 2009)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2009 | Amount | Series D - Gloucester Pharmaceuticals | Valuation | Novo Holdings | |
| Aug, 2009 | Amount | Seed - Gloucester Pharmaceuticals | Valuation |
investors |
|
| Jul, 2009 | Amount | Seed - Gloucester Pharmaceuticals | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Gloucester Pharmaceuticals
Gloucester Pharmaceuticals has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Celgene, Apple Tree Partners and ProQuest Investments. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Apple Tree Partners is engaged in life sciences venture capital.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Investments are made in US life sciences and healthtech firms.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Gloucester Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Gloucester Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Gloucester Pharmaceuticals Comparisons
Competitors of Gloucester Pharmaceuticals
Gloucester Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Jazz Pharmaceuticals, BeiGene, Advanced Accelerator Applications and Incyte, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Targeted and immune-oncology drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Radiopharmaceuticals for oncology diagnostics and therapies are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Small molecules are developed for cancer and skin disease treatments.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Gloucester Pharmaceuticals
Frequently Asked Questions about Gloucester Pharmaceuticals
When was Gloucester Pharmaceuticals founded?
Gloucester Pharmaceuticals was founded in 2002 and raised its 1st funding round 7 years after it was founded.
Where is Gloucester Pharmaceuticals located?
Gloucester Pharmaceuticals is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is Gloucester Pharmaceuticals a funded company?
Gloucester Pharmaceuticals is a funded company, having raised a total of $33M across 5 funding rounds to date. The company's 1st funding round was a Seed of $500K, raised on Mar 30, 2009.
What does Gloucester Pharmaceuticals do?
Gloucester Pharmaceuticals was founded in 2002 and is based in Cambridge, United States. Operations focus on oncology pharmaceuticals, with romidepsin identified as a key compound in late-stage development for hematological malignancies. Worldwide exclusive rights to romidepsin, classified as a histone deacetylase (HDAC) inhibitor targeting Class I, II, and IV enzymes, are retained by the company. Preclinical data indicate its potential across various cancer types.
Who are the top competitors of Gloucester Pharmaceuticals?
Gloucester Pharmaceuticals's top competitors include Moderna, Jazz Pharmaceuticals and Advanced Accelerator Applications.
Who are Gloucester Pharmaceuticals's investors?
Gloucester Pharmaceuticals has 6 investors. Key investors include Celgene, Apple Tree Partners, ProQuest Investments, Prospect Venture Partners, and Rho Capital Partners.